Announced Mon, 18 May · 14:32 IST

Rotation of Statutory Auditors in FY28

Management Changes View source PDF

STAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.0%1-day move
₹1146.80
prior close
₹1168.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-3.1-3.7-0.1-0.0-0.2+1.5-0.2+3.3+1.1-10.9-3.5-8.0
Up moveDown movePending
AI summary

Strides Pharma Science has announced the planned rotation of its statutory auditors. Current auditors B S R & Co. LLP are completing their second consecutive five-year term at the conclusion of the 36th AGM in 2027. Based on the Audit Committee's recommendation, the Board has approved proposing M/s. Deloitte Haskins & Sells LLP as the new statutory auditor for a five-year term from the 36th AGM (2027) through the 41st AGM (2032). This rotation is a standard regulatory compliance exercise as mandated by SEBI's audit firm rotation guidelines, requiring a change after 10 years of continuous service.

Likely market impact

This is a routine, planned auditor rotation with no governance concerns. The changeover will occur after shareholder approval at the 2027 AGM, ensuring continuity in audit services. Investors should note this as a standard compliance update with no material impact on the company's financial reporting or stock outlook.